Announce Date | 05/21/2025 |
EPS Normalized Actual | $0.92 (Beat by $0.005) |
EPS GAAP Actual | $0.92 (Beat by $0.005) |
Revenue Actual | $13.111B |
Revenue Surprise | Beat by $13111M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Feb 2030 | 6.795 | 18.46 | 6.66032 | 6.91793 | 1 |
Feb 2030 | 6.795 | 18.46 | 6.6601 | 6.92192 | 4 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (May 2025) | 0.92 | 0.92 | 13.111B | 4.82% | 13111M |
FQ1 2025 (Feb 2025) | 1.23 | 1.23 | 16.35B | -0.37% | 16350M |
FQ4 2024 (Nov 2024) | 1.14 | 1.14 | 14.063B | 5.67% | 14063M |
FQ3 2024 (Aug 2024) | 0.96 | 0.96 | 13.468B | 5.27% | 13468M |
FQ2 2024 (Apr 2024) | 0.93 | 0.93 | 12.479B | 5.58% | 12479M |
FQ1 2024 (Jan 2024) | 1.22 | 1.22 | 16.411B | 11.52% | 16411M |
FQ4 2023 (Oct 2023) | 1.04 | 1.04 | 13.265B | 8.28% | 13265M |
FQ3 2023 (Jul 2023) | 0.86 | 0.86 | 12.758B | 7.17% | 12758M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2027 (Feb 2027) | 1.4766 | -- | 1.45711 | 1.5039 | 6 |
FQ4 2026 (Nov 2026) | 1.33633 | -- | 1.31869 | 1.36103 | 6 |
FQ3 2026 (Aug 2026) | 1.13308 | -- | 1.11813 | 1.15403 | 6 |
FQ2 2026 (May 2026) | 0.97786 | 5.92 | 0.96495 | 0.99594 | 8 |
FQ1 2026 (Feb 2026) | 1.34395 | 8.48 | 1.32706 | 1.35794 | 5 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2027 (Feb 2027) | 17.87B | -- | 17.68B | 18.12B | 9 |
FQ4 2026 (Nov 2026) | 15.32B | -- | 15.16B | 15.54B | 13 |
FQ3 2026 (Aug 2026) | 14.71B | -- | 14.56B | 14.92B | 8 |
FQ2 2026 (May 2026) | 13.51B | 2.92 | 13.37B | 13.7B | 8 |
FQ1 2026 (Feb 2026) | 17.02B | 3.91 | 16.85B | 17.15B | 6 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (May 2025) | 0.92 | 0.92 | 100% | |
FQ1 2025 (Feb 2025) | 1.23 | 1.23 | 100% | |
FQ4 2024 (Nov 2024) | 1.14 | 1.14 | 100% | |
FQ3 2024 (Aug 2024) | 0.96 | 0.96 | 100% | |
FQ2 2024 (Apr 2024) | 0.93 | 0.93 | 100% | |
FQ1 2024 (Jan 2024) | 1.22 | 1.22 | 100% | |
FQ4 2023 (Oct 2023) | 1.04 | 1.04 | 100% | |
FQ3 2023 (Jul 2023) | 0.86 | 0.86 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (May 2025) | $0B | $13.11B | $13111M | 100% |
FQ1 2025 (Feb 2025) | $0B | $16.35B | $16350M | 100% |
FQ4 2024 (Nov 2024) | $0B | $14.06B | $14063M | 100% |
FQ3 2024 (Aug 2024) | $0B | $13.47B | $13468M | 100% |
FQ2 2024 (Apr 2024) | $0B | $12.48B | $12479M | 100% |
FQ1 2024 (Jan 2024) | $0B | $16.41B | $16411M | 100% |
FQ4 2023 (Oct 2023) | $0B | $13.27B | $13265M | 100% |
FQ3 2023 (Jul 2023) | $0B | $12.76B | $12758M | 100% |